The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Aviceda Therapeutics has hit a snag in its goal to deliver a new treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. The biotech’s lead asset, AVD-104, ...
SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...
In life, it’s important to savor every moment. Take Ken, a man from Reno who is living a full life at an age when most people would be long retired. Eleven years ago – at age 77 – he began working as ...
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the best upside stocks to buy now. On November 12, Apellis Pharmaceuticals announced that a post hoc analysis of the Phase 3 GALE extension study ...
Annexon Inc. (ANNX) is still a "Buy" in my view, driven by progress in its c1q inhibitor pipeline for rare diseases. ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned ...
Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.
Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...
Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the world nearly blind. A new clinical study provides a possible solution that ...
To reach the target audience of geographic atrophy (GA) treatment Izervay, Astellas Pharma has turned to the “internet’s grandma,” cookbook author and popular social media creator Barbara “Babs” ...
ORLANDO -- The PRIMA system combining a subretinal photovoltaic implant and eyeglasses that project near-infrared light to the implant significantly improved vision in patients with geographic atrophy ...